The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance status

Neuro-Oncology

Volumn 1, Issue 3, 1999, Pages 196-203

  O'Neill, Brian P ^a   Wang, Chiao Hua ^b   O'Fallon, Judith R ^b   Colgan, Joseph P ^b   Earle, John D ^b   Krigel, Robert L ^b   Brown, Loren D ^b   McGinnis, William J ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; COGNITIVE DEFECT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RADIATION INJURY; SKULL IRRADIATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREDNISONE; PSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VINCRISTINE;

EID: 0033157375     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/1.3.196     Document Type: Article

References (37)

1. Abrey, L.E., DeAngelis, L.M., and Yahalom, J. (1998) Long-term survival in primary CNS lymphoma. J. Clin. Oncol. 16, 859-863.
2. Allen, J.C., Rosen, G., Mehta, B.M., and Horten, B. (1980) Leukoencephalopathy following high-dose IV methotrexate chemotherapy with leukovorin rescue. Cancer Treat Rep. 64, 1261-1273.
3. Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Eghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J.P., Le Mevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F., and Biron, P. (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series. J. Clin. Oncol. 16, 864-871.
4. Brada, M., Dearnaley, D., Horwich, A., and Bloom, H.J. (1990) Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone. Int. J. Radiat. Oncol. Biol. Phys. 18, 787-792.
5. Cote, T.R., Manna, A., Hardy, C.R., Yellin, F.J., and Hartge, P. (1996) Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J. Natl. Cancer. Inst. 88, 675-679.
6. Crossen, J.R., Garwood, D., Glatstein, E., and Neuwelt, E.A. (1994) Neurobehavioral sequalae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J. Clin. Oncol. 12, 627-642.
7. DeAngelis, L.M., Delattre, J.Y., and Posner, J.B. (1989) Radiation-induced dementia in patients cured of metastases. Neurology 39, 789-796.
8. DeAngelis, L.M., Yahalom, J., Heinemann, M.H., Cirrincione, C., Thaler, H.T., and Krol, G. (1990) Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology 40, 80-86.
9. Eby, N.L., Grufferman, S., Flannelly, C.M., Schold, S.C., Jr., Vogel, F.S., and Burger, P.C. (1988) Increasing incidence of primary brain lymphoma in the U.S. Cancer 62, 2461-2465.
10. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glock, J.H., Coltman, C.A., Jr., and Miller, T.P. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 328, 1002-1006.
11. Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
12. Freilich, R.J., Delattre, J.Y., Monjour, A., and DeAngelis, L.M. (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46, 435-439.
13. Frick, J.C., Hansen, R.M., Anderson, T., and Ritch, P.S. (1986) Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma. Arch. Intern. Med. 146, 791-792.
14. Glass, J., Gruber, M.L., Cher, L., and Hochberg, F.H. (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J. Neurosurg. 81, 188-195.
15. Henry, J.M., Heffner, R.R., Jr., Dillard, S.H., Earle, K.M., and Davis, R.L. (1974) Primary malignant lymphomas of the central nervous system. Cancer 34, 1293-1302.
16. Hochberg, F.H., and Pruitt, A. (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30, 907-911.
17. Hochberg, F.H., and Slotnick, B. (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30, 172-177.
18. Kaplan, E.L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat Assoc. 53, 457-481.
19. MacDonald, D.R., Cascino, T.L., Schold, S.C., Jr., and Cairncross, J.G. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 8, 1277-1280.
20. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. Pt. 1 50, 163-170.
21. Murray, K.J., Nelson, D.F., Scott, C., Fischbach, A.J., Porter, A., Farnan, N., and Curran, W.J., Jr. (1995) Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of Radiation Therapy Oncology Group (RTOG) 83-02. Int. J. Radiat. Oncol. Biol. Phys. 31, 453-459.
22. Nelson, D.F., Martz, K.L., Bonner, H., Nelson, J.S., Newall, J., Kerman, H.D., Thomson, J.W., and Murray, K.J. (1992) Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys. 23, 9-17.
23. Nesbitt, J.C., Lee, J.S., Komaki, R., and Roth, J.A. (1997) Cancer of the lung. In: Holland, J.F., Bast, R.C., Jr., Morton, D.L., Frei, E., III, Kufe, D.W., Weichselbaum, R.R. (Eds.), Cancer Medicine. Fourth edition. Philadelphia: Williams and Wilkins. pp. 1723-1803.
24. Neuwelt, E.A., Goldman, D.L., Dahlborg, S.A., Crossen, J., Ramsey, F., Roman-Goldstein, S., Braziel, R., and Dana, B. (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitve function. J. Clin. Oncol. 9, 1580-1590.
25. O'Neill, B.P., O'Fallon, J.R., Earle, J.D., Colgan, J.P., Brown, L.D., and Krigel, R.L. (1995) Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy? Int. J. Radiat. Oncol. Biol. Phys. 33, 663-673.
26. O'Neill, B.P., and Illig, J. (1989) Primary central nervous system lymphoma. Mayo Clin. Proc. 64, 1005-1020.
27. O'Neill, B.P., Tomlinson, F.H., O'Fallon, J.R., Scherthauer, B.W., Kurtin, P.J., and O'Neill, D.B. (1993) The continuing increase of primary central nervous system non-Hodgkin's lymphoma (PCNSL). Ann. Neurol. 34, 313.
28. Poisson, M., Hauw, J.J., Pouillart, P., Bataini, J.P., Mashaly, R., Pertuiset, B.F., and Metzger, J. (1979) Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy. Acta. Neurochir. (Wien) 51, 27-42.
29. Schiffer, D., Chio, A., Giordana, M.T., Novero, D., Palestro, G., Soffietti, R., and Vasario, E. (1987) Primary lymphomas of the brain: A clinicopathologic review of 37 cases. Tumori 73, 585-592,.
30. Shibamoto Y., Tsutsui, K., Dodo, Y., Yamabe, H., Shima, N., and Abe, M. (1990) Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65, 1907-1912.
31. So, N.K. , O'Neill, B.P., Frytak, S., Eagan, R.T., Earnest, F., IV, and Lee, R.E. (1987) Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology 37, 1198-1201.
32. Taylor, B.V., Buckner, J.C., Cascino, T.L., O'Fallon, J.R., Schaefer, P.L., Dinapoli, R.P., and Schomberg, P. (1998) Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J. Clin. Oncol. 16, 2195-2201.
33. Tomlinson, F.H., Kurtin, P.J., Suman, V.J., Scheithauer, B.W., O'Fallon, J.R., Delly, P.J., Jack, C.R., Jr., and O'Neill, B.P. (1995) Primary intracerebral malignant lymphoma: A clinicopathological study of 89 patients. J. Neurosurg. 82, 558-566.
34. Tondini, C., Zanini, M., Lombardi, F., Bengala, C., Rocca, A., Giardini, R., Buzzoni, R., Valagussa, P., and Bonadonna, G. (1993) Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. J. Clin. Oncol. 11, 720-725.
35. Trojanowski, T. Peszynski, J., Turowski, K., Markiewicz, P., Goscinski, I., Bielawski, A., Bendarzewska, B., Szymona, J., Dabrowska, A., and Lopatkiewicz, J. (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J. Neurosurg. 70, 18-23.
36. Weitzner, M.A., Meyers, C.A., and Byrne, K. (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J. Neurosurg. 84, 29-34.
37. Wilcoxon, F. (1945) Individual comparisons by ranking methods. Biometrics 1, 80-83.